Adjunctive therapy in treatment for head and neck cancer.
Improvement in tumor-free intervals and cure rates of patients with cancer of the head and neck will almost certainly come from utilization of more than one type of treatment in the same patient. For example, in treatment for formidable lesions this might take the form of a short course of preoperative chemotherapy followed by surgery. Postoperative chemotherapy might then be employed in preoperative responders, with the addition of radiation according to the usual postoperative indications. Specific or nonspecific immunotherapy might be used on a long-term basis, preoperatively and postoperatively. In selected patients, utilization of multiple modalities early in a careful long-term plan may bring improvement over current results from employment of adjuvant measures only after recurrence or metastatic spread is clinically obvious.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D010478:Chemotherapy, Cancer, Regional Perfusion; D003452:Cryosurgery; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008545:Melanoma / Q000628:therapy; D037981:Neck Dissection; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010166:Palliative Care; D011182:Postoperative Care
D000970:Antineoplastic Agents